Chaeum Premium No. 1: A Professional Sourcing Guide for Clinics

Chaeum Premium No. 1 is a monophasic hyaluronic acid (HA) dermal filler manufactured by Hugel, a South Korean firm recognized in the aesthetic sector. As an injectable solution, it is intended for specific aesthetic indications requiring HA-based soft tissue augmentation.

Professionals consider Chaeum Premium No. 1 for its specific formulation within the broader category of Hyaluronic acid dermal filler catalog products available for clinic stock. Understanding its technical profile is key to integrating it into an existing product portfolio.

The primary active component of Chaeum Premium No. 1 is cross-linked hyaluronic acid, typically at a concentration of 20 mg/mL. This specific concentration is often considered suitable for its intended applications. The filler is known for its monophasic structure, which contributes to its flow properties during injection.

Each unit of Chaeum Premium No. 1 is commonly supplied in a pre-filled syringe, typically 1.1 mL in volume, accompanied by two sterile needles. This presentation aims to provide convenience and accuracy for aesthetic practitioners during preparation and application. Clinic stock management should account for these standard packaging specifications.

Chaeum Premium No. 1 is generally considered by aesthetic professionals for targeted applications involving finer lines and superficial wrinkles. Its specific rheological properties suggest suitability for areas where a softer correction is desired. Common considerations include forehead lines, periorbital rhytids, and perioral lines, subject to professional assessment and patient suitability.

Like Elasty Plus 1CC and similar fillers, the appropriate application depends on the injector's technique, anatomical understanding, and the specific aesthetic goals discussed with the patient. Clinic protocols should ensure product selection aligns with patient needs and desired outcomes.

The aesthetic effects of Chaeum Premium No. 1, typical of hyaluronic acid fillers, can vary in duration. Factors influencing longevity include individual patient metabolism, the specific injection site, the volume of product administered, and the patient's lifestyle. Practitioners typically observe an effect duration ranging between 6 to 12 months for fillers in this category. However, these are general estimations, and individual results will vary.

Effective patient counseling by professionals should include a realistic discussion of expected duration and the potential need for follow-up treatments to maintain results. Regular patient review allows for timely assessment and planning for maintenance sessions.

Acquiring Chaeum Premium No. 1 for your clinic involves sourcing through established wholesale channels. This approach ensures access to authentic products and competitive pricing structures designed for professional buyers. Our platform supports a transparent volume-based purchasing model for aesthetic injectables.

Consider the following illustrative pricing tiers for Chaeum Premium No. 1 (price per unit, USD):

We implement a flexible, MOQ-light policy to accommodate varying clinic inventory needs. For further guidance on efficient sourcing strategies, refer to our Sourcing LEXYAL Wholesale: A Professional Buyer's Guide.

Correct handling and storage are critical for maintaining the integrity and efficacy of Chaeum Premium No. 1. Products should be stored in their original packaging, away from direct sunlight and extreme temperatures, within the manufacturer's specified range. A consistent cold chain is maintained from our facility to your clinic to protect product stability.

It is imperative for clinic staff to adhere to proper aseptic techniques during preparation and administration. Consult the product's official instructions for specific storage requirements and handling recommendations to ensure optimal performance and patient safety. For broader guidelines on product care, refer to resources such as Restylane Kysse: A Professional Guide to Handling and Storage.